14 March 2019

In Clinical Infectious Diseases Angela Colbers, Stein Schalkwijk and David Burger give considerations on how to effectively evaluate aspects of clinical pharmacology required for safe and effective treatment to optimize pharmacotherapy during pregnancy and breastfeeding. They advocate for shortening the time period between registration of antiretroviral drugs and first pregnancy data becoming available.

Recently, the FDA and EMA issued warnings on the use of dolutegravir and darunavir/cobicistat for treatment of pregnant women living with HIV. It took 3 to 5 years to identify the risks associated with the use of these antiretroviral drugs, during which time pregnant women were exposed to these drugs in clinical care, outside of controlled clinical trial settings. Across all antiretroviral drugs, the interval between registration of new drugs and first data on pharmacokinetics and safety in pregnancy becoming available is around 6 years.

Publication
Importance of prospective studies in pregnant and breastfeeding women living with HIV.
Colbers A, Mirochnick M, Schalkwijk S, Penazzato M, Townsend C, Burger D.

Angela Colbers, Stein Schalkwijk and David Burger are members of theme Infectious diseases and global health.
 

Related news items


RIHS Open Day We are looking for enthusiastic researchers!

21 March 2019

On Sunday 6 October 2019 we will again open our doors and show our wonderful research to the general public.

read more

Bart Kiemeney will step down as director RIHS Invitation

21 March 2019

We would like to give you the opportunity to say goodbye to Bart as director of the Radboud Institute for Health Sciences on 28 March 16.00 hrs in the Tuinzaal.

read more

Publication on nanoparticle imaging agent

21 March 2019

Mangala Srinivas, theme Nanomedicine, showed in Advanced Functional Materials that nano‐particles (radius 100 nm), are suitable for long‐term in vivo ultrasound in combination with 19F MRI and fluorescence.

read more

Protein supplementation improves lean body mass in physically active older adults

21 March 2019

In the Journal of Cachexia, Sarcopenia & Muscle, Dominique ten Haaf and colleagues described a randomized clinical trial to assess the effects of 12-weeks protein supplementation on body characteristics.

read more

eHealth Apps Replacing or Complementing Health Care Contacts

21 March 2019

In the Journal of Medical Internet Research, Pim Assendelft and colleagues from the University of Applied sciences Arnhem Nijmegen showed that still relatively little is known about the adverse effects of health apps when used to replace or complement contacts with doctors or nurses.

read more

Proudly presenting new theme leaders

20 March 2019

It is our pleasure to introduce the new leaders of the themes Mitochondrial diseases, Reconstructive and regenerative medicine and Vascular damage.

read more